Insights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others

Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Pharma Ophthalmic Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.

This report describes the global market size of Pharma Ophthalmic from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

This report covers the following regions:

• North America

• South America

• Asia & Pacific

• Europe

• MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Pharma Ophthalmic as well as some small players.

The information for each competitor includes:

• Company Profile

• Main Business Information

• SWOT Analysis

• Sales Volume, Revenue, Price and Gross Margin

• Market Share

Applications Segment:

• Glaucoma

• Dry eye syndrome

• Retinal diseases

• Other ophthalmic indications

Types Segment:

• Retinal disorders drugs

• Allergic

Companies Covered:

• Novartis

• Allergan

• Roche

• Valeant

• Regeneron

• Santen

• Bayer

• Pfizer

• Senju

• Akorn

Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Pharma Ophthalmic Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Trading Analysis
8.1 Export of Pharma Ophthalmic by Region
8.2 Import of Pharma Ophthalmic by Region
8.3 Balance of Trade

Chapter 9 Historical and Forecast Pharma Ophthalmic Market in North America (2016-2026)
9.1 Pharma Ophthalmic Market Size
9.2 Pharma Ophthalmic Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico

Chapter 10 Historical and Forecast Pharma Ophthalmic Market in South America (2016-2026)
10.1 Pharma Ophthalmic Market Size
10.2 Pharma Ophthalmic Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru

Chapter 11 Historical and Forecast Pharma Ophthalmic Market in Asia & Pacific (2016-2026)
11.1 Pharma Ophthalmic Market Size
11.2 Pharma Ophthalmic Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southeast Asia
11.5.6 Australia

Chapter 12 Historical and Forecast Pharma Ophthalmic Market in Europe (2016-2026)
12.1 Pharma Ophthalmic Market Size
12.2 Pharma Ophthalmic Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia

Chapter 13 Historical and Forecast Pharma Ophthalmic Market in MEA (2016-2026)
13.1 Pharma Ophthalmic Market Size
13.2 Pharma Ophthalmic Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey

Chapter 14 Summary For Global Pharma Ophthalmic Market (2016-2021)
14.1 Pharma Ophthalmic Market Size
14.2 Pharma Ophthalmic Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

Chapter 15 Global Pharma Ophthalmic Market Forecast (2021-2026)
15.1 Pharma Ophthalmic Market Size Forecast
15.2 Pharma Ophthalmic Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

Chapter 16 Analysis of Global Key Vendors
16.1 Novartis
16.1.1 Company Profile
16.1.2 Main Business and Pharma Ophthalmic Information
16.1.3 SWOT Analysis of Novartis
16.1.4 Novartis Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.2 Allergan
16.2.1 Company Profile
16.2.2 Main Business and Pharma Ophthalmic Information
16.2.3 SWOT Analysis of Allergan
16.2.4 Allergan Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.3 Roche
16.3.1 Company Profile
16.3.2 Main Business and Pharma Ophthalmic Information
16.3.3 SWOT Analysis of Roche
16.3.4 Roche Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.4 Valeant
16.4.1 Company Profile
16.4.2 Main Business and Pharma Ophthalmic Information
16.4.3 SWOT Analysis of Valeant
16.4.4 Valeant Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.5 Regeneron
16.5.1 Company Profile
16.5.2 Main Business and Pharma Ophthalmic Information
16.5.3 SWOT Analysis of Regeneron
16.5.4 Regeneron Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.6 Santen
16.6.1 Company Profile
16.6.2 Main Business and Pharma Ophthalmic Information
16.6.3 SWOT Analysis of Santen
16.6.4 Santen Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.7 Bayer
16.7.1 Company Profile
16.7.2 Main Business and Pharma Ophthalmic Information
16.7.3 SWOT Analysis of Bayer
16.7.4 Bayer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.8 Pfizer
16.8.1 Company Profile
16.8.2 Main Business and Pharma Ophthalmic Information
16.8.3 SWOT Analysis of Pfizer
16.8.4 Pfizer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.9 Senju
16.9.1 Company Profile
16.9.2 Main Business and Pharma Ophthalmic Information
16.9.3 SWOT Analysis of Senju
16.9.4 Senju Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)
16.10 Akorn
16.10.1 Company Profile
16.10.2 Main Business and Pharma Ophthalmic Information
16.10.3 SWOT Analysis of Akorn
16.10.4 Akorn Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2016-2021)

For more information about this report visit https://www.researchandmarkets.com/r/xcfomx

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900